Back to Search Start Over

Hemostatic alterations in fatty liver disease

Authors :
Ali Koşar
Cemile Koca
Ebru Uz
Benan Kasapoglu
Sema Uysal
Mustafa Ikizek
Feridun Karakurt
Ozlem Sahin Balcik
Murat Aydin
Ayse Kargili
Handan Cipil
Source :
Blood Coagulation & Fibrinolysis. 21:325-327
Publication Year :
2010
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2010.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is an important cause of liver failure. Whatever its cause, the liver failure is accompanied by multiple changes in the hemostatic system. The objective of the current report was to study several homeostasis parameters such as protein C, protein S, factor 7, factor 8 levels, platelet counts, prothrombin time and activated partial thromboplastin time, and plasminogen activator inhibitor in patients with fatty liver. A total of 28 consecutive patients with ultrasound proven NAFLD and 33 healthy volunteers were included in the study. Plasma prothrombin time and activated partial thromboplastin time were within normal ranges in both NAFLD and control groups. Plasma factor 7, factor 8, protein S, and protein C levels were decreased in NAFLD patients but the difference was not statistically significant, whereas plasminogen activator inhibitor 1 levels were significantly increased in patients with NAFLD compared to controls. In conclusion, in all types of liver disease, some alterations in hemostatic parameters are awaited. As fatty liver disease is very common in clinical practice, clinicians should be aware of this kind of alterations.

Details

ISSN :
09575235
Volume :
21
Database :
OpenAIRE
Journal :
Blood Coagulation & Fibrinolysis
Accession number :
edsair.doi.dedup.....37ae887e82de80817fe37b0119927b65
Full Text :
https://doi.org/10.1097/mbc.0b013e328337b3f8